For EZH2, miR-138-5p had binding sites identified in 5 software packages, and most miRNAs with 3UTR binding sites were downregulated in BC subtypes (miR-455-3p, miR-487a and miR-487b). This evidence concerns the gene EZH2 and breast cancer.